本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Adaptimmune Therapeutics plc

0.0549
0.0000
成交量:- -
成交額:- -
市值:1,455.13萬
市盈率:-0.08
高:0.0549
開:0.0549
低:0.0549
收:0.0549
52周最高:0.8100
52周最低:0.0403
股本:2.65億
流通股本:1.83億
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.6574
每股收益(LYR):-0.2807
淨資產收益率:-1341.10%
總資產收益率:-40.86%
市淨率:-0.21
市盈率(LYR):-0.20

資料載入中...

2025/10/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/10/28

自願退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/10/20

重要事件披露

Form 8-K - Current report
2025/09/26

重要事件披露

Form 8-K - Current report
2025/09/12

重要事件披露

Form 8-K - Current report
2025/09/09

重要事件披露

Form 8-K - Current report
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/29

重要事件披露

Form 8-K - Current report
2025/08/15

重要事件披露

Form 8-K - Current report
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

重要事件披露

Form 8-K - Current report
2025/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/08/08

重要事件披露

Form 8-K - Current report
2025/07/31

重要事件披露

Form 8-K - Current report
2025/07/28

重要事件披露

Form 8-K - Current report